Bharat Parenterals logo

Bharat Parenterals financials: balance sheet, profit and loss, cash flow

NSE: BPLPHARMABSE: 541096Pharmaceuticals & BiotechnologySmall Cap

Bharat Parenterals Limited · Face value ₹10 · Listed Mar 2018
Last close ₹1,912.60down ₹0.30 (0.02%)BSE ₹1,910.15

Share price at the NSE close on 29 Oct 2026. Previous close ₹1,912.90.

29 Oct: open ₹1,912.90, high ₹1,932.00, low ₹1,869.10

52-week range of BSE trades to 29 Oct 2026
₹880.25Low, 30 Mar 2026₹2,274.10High, 28 Sep 2026
Market cap
₹1,318 Cr1,597th largest listed
P/E
1,059.70
P/B
3.97
Dividend yield
0.05%
ROE
0.4%
ROCE
−0.3%
Debt to equity
0.50
Volume, NSE
4,33268.7% delivered

Bharat Parenterals' financial statements for the 9 years to Mar 2026, consolidated: the company and its subsidiaries together, with the half year to Sep 2026 after them.

9 years at a glance

₹ crore, years to March.Bharat Parenterals annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
1399.1Mar 18220212.9Mar 19228240.7Mar 20205209.8Mar 212122118Mar 222181650Mar 232571184Mar 24340−44180Mar 25345−27146Mar 26
Peak revenue ₹345 Cr, year to Mar 2026; lowest ₹139 Cr, year to Mar 2018A loss in 2 of the 9 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin
13.2%−12.8%13.2%12.3%12.3%13.0%9.1%8.7%0.8%4.6%6.6%9.7%10.6%9.9%9.8%7.2%4.1%−12.8%−7.9%Mar 18Mar 20Mar 22Mar 24Mar 26

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue345
  2. Materials and goods−191
  3. Employee costs−67
  4. Other expenses−71
  5. Operating profit16
  6. Depreciation−34
  7. Other income+9.5
  8. One-off items0.0
  9. Finance costs−13
  10. Profit before tax−21
  11. Tax−5.9
  12. Net profit−27

What the company owns

  • Plant, investments and other assets₹361 Cr
  • Receivables₹151 Cr
  • Inventory₹85 Cr
  • Cash and bank₹12 Cr
  • Current investments₹5 Cr

What pays for it: net worth and liabilities

  • Net worth₹312 Cr
  • Borrowings₹146 Cr
  • Other liabilities₹92 Cr
  • Owed to suppliers₹64 Cr

Profit and loss

Consolidated, ₹ crore, years to March. The last column is the twelve months to Sep 2026, the latest four quarters added.Bharat Parenterals quarterly results

₹ croreMar 2018Mar 2019Mar 2020Filed 20 JunMar 2021Filed 5 JunMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 18 MaySep 2026Twelve monthsFiled 29 Oct
Revenue from operations139220228205212218257340345395
–191200179184198235338330361
Materials and goods bought88140149134136137158185191205
Employee costs–151615151823506776
Other expenses–3536303343541037181
Operating profit before depreciation–29282528202231633
Operating margin–13.2%12.3%12.3%13.0%9.1%8.7%0.8%4.6%8.4%
Materials, % of revenue–64.0%65.3%65.6%64.2%63.1%61.5%54.5%55.4%51.9%
Employee costs, % of revenue–7.0%6.8%7.2%7.2%8.3%8.9%14.6%19.5%19.2%
Other expenses, % of revenue–15.9%15.6%14.9%15.5%19.6%20.9%30.1%20.5%20.4%
Depreciation and amortisation–666769353435
Operating profit after depreciation–232219211413−33−18−1
Other income713119812912109
Finance costs1111123131311
One-off items0000000000
Profit before tax13353327282419−34−21−4
41397788–65
9212420211611−44−27−10
Other comprehensive income–000000011
Total comprehensive income–212420211610−43−27−9
Net margin6.6%9.7%10.6%9.9%9.8%7.2%4.1%−12.8%−7.9%−2.4%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2018: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given. Belonging to the company's shareholders is left blank for the year to Mar 2024: the filing's earnings per share does not match the profit it states, and cannot be multiplied back into the owners' profit because the share it leaves the other owners is more than 10 points from the share the company's other periods state. Tax is left blank for the year to Mar 2025: profit before tax less the tax charge stated does not come to the profit after tax the same statement states, so the tax charge is not shown. Belonging to outside owners of subsidiaries is left blank for the year to Mar 2025: the filing states 0 for this share both for the period and for the year so far, which the form also writes for a line it does not fill, while the company's other filings for the same year show it was not 0 over those months.

Balance sheet

Consolidated, ₹ crore, at 31 March. The last column is the half year to Sep 2026, after the latest full year: the balance sheet at its end.

₹ croreMar 2019Mar 2020Filed 20 JunMar 2021Filed 5 JunMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 18 MaySep 2026Half yearFiled 29 Oct
94118144170218238339312319
94118144166183197331322332
Share capital666666777
Reserves88112138160177191324315325
Belonging to outside owners of subsidiaries000435418−11−13
3110185084180146160
61664442120190219157193
431114137590144151
Total assets159188199226350504649613664
41565182166244293300369
118132148144184260356313295
Net debt−11−10−3524072118129135
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the year to Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March. The last column is the half year to Sep 2026, after the latest full year: the cash flow over its six months.

₹ croreMar 2021Filed 5 JunMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 18 MaySep 2026Half year
31−122−5−273883
385315−174888
0−28−2−29−292148
Receivables12−50−28−25179
Inventories62−17−24−10−130
Payables−16−2−5915−1012
Other working capital−1−221914−82628
Tax paid−7−60−9−11−10−5
Interest paid0000000
Capital spending63992104294028
Free cash flow25−40−70−109−56−255
−48−7−78−105−1379−86
8961110156−478
Dividends paid0000111
Shares bought back0000000
Shares issued000014700
Net change in cash−8241−815
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.Bharat Parenterals dividend history

₹ per shareMar 2018Mar 2019Mar 2020Filed 20 JunMar 2021Filed 5 JunMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 18 May
Earnings per share₹15.91₹37.08₹42.14₹35.59₹36.67₹28.40₹8.65−₹66.64−₹39.62
Diluted earnings per share₹15.91₹37.08₹42.14₹35.59₹36.67₹28.40₹8.65−₹66.64−₹39.62
Dividend per share–––––₹0.75₹1.00₹1.00₹1.00
Book value per share–₹164.07₹206.28₹251.43₹287.15₹316.79₹338.97₹479.93₹467.55
Dividend payout–––––2.6%–––
Shareholder yield–––0.0%−0.2%0.0%0.0%−21.6%0.1%
Market cap at the year end (₹ crore)11712681192196194648681620

Ratios

Consolidated, years to March.Bharat Parenterals PE ratio and valuation

RatioMar 2019Mar 2020Filed 20 JunMar 2021Filed 5 JunMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 18 May
Revenue growth58.5%3.9%−10.3%3.6%2.8%18.1%32.3%1.5%
Operating profit growth–−2.8%−10.1%9.5%−28.1%12.5%−87.9%485.8%
Net profit growth133.1%13.7%−15.9%2.5%−24.5%−33.1%––
Earnings per share growth133.1%13.6%−15.5%3.0%−22.6%−69.5%––
22.6%22.8%15.6%13.6%9.4%–−16.5%−2.5%
–0.2 pts−7.2 pts−2.0 pts−4.2 pts––14.0 pts
From the net margin–2.1 pts−1.3 pts−0.1 pts−3.3 pts––13.5 pts
From asset turnover–−1.1 pts−4.2 pts−0.9 pts−2.5 pts––0.2 pts
From borrowing–−0.8 pts−1.7 pts−1.0 pts1.6 pts––0.3 pts
Return on capital employed23.5%18.7%12.5%11.2%5.2%4.1%−6.3%−4.0%
Cash conversion––153.9%−5.1%137.8%−44.8%––
Interest cover26.225.824.923.66.44.1––
Debt to equity0.030.010.070.100.230.350.530.47
Receivable days106127121126188201184159
Inventory days59716156100142142162
Payable days831047164155138146122
Cash conversion cycle, days8293111118134204180199
Working capital days7688108157156201191172
Asset turnover1.381.321.061.000.760.600.590.55
Assets per rupee of net worth1.691.631.471.371.652.252.181.93
Sales per rupee of plant6.467.194.725.335.291.231.711.71
Capital spending to depreciation––0.975.8515.5811.560.821.17
Plant being built, % of plant in use3.1%38.3%1.0%64.5%240.4%11.4%15.2%16.8%
Interest cover is left blank for the years to Mar 2025 and Mar 2026: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the year to Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
−1.3%
Cash from operations against operating profit
242.5%
Measure10 years5 years3 years
Revenue growth, yearly rate–11.0%16.6%
Return on equity, average–1.0%−9.5%
Return on capital employed, average–2.0%−2.1%
Operating margin, average–7.2%4.7%
Net margin, average4.1%0.1%−5.5%
Asset turnover, average–0.700.58
Cash conversion cycle, days, average–167194
Debt to equity, average–0.340.45

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations27638
Cash from investing−317−2339
Cash from financing289219−47
Capital spending30417340
Dividends paid221
Shares bought back000
Shares issued for cash1481480
Borrowings raised11911446
Borrowings repaid17514280

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9–––536334
Altman Z-scorePublished threshold 1.81–4.493.775.195.012.672.832.692.77
Beneish M-scorePublished threshold −1.78–––−3.04−0.31−2.04−2.29−2.23−2.95
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–––19.1613.4324.9428.1020.95−11.89
Cash from operations to profit, 3 yearsPublished threshold 0.7 times–––––0.910.34––
Receivables growth less revenue growthOur threshold 0 percentage points––20.31−4.204.6150.337.74−10.82−13.76
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––21.96−12.33−8.7981.2347.26−0.0814.55
Other current assets growth less revenue growthOur threshold 5 per cent of revenue––−2.17−0.3610.91−4.278.101.423.16
Assets under construction, years of additionsOur threshold 2 years of additions––3.330.028.4113.530.131.220.92
Effective tax ratePublished threshold 17.16 per cent28.7438.5826.3625.1125.3633.2543.96––
Tax charged less tax paid, % of profitOur threshold 10 percentage points––––5.0233.25−6.57––
A threshold marked as ours has no published figure; it is the line we read the check against.